passages.id: 191
passages.type: sentence
passages.text: Our results suggest that both drugs were well tolerated in patients with AML or MDS who received chemotherapy and that the efficacy of itraconazole for prophylaxis against systemic fungal disease is not inferior to that of fluconazole .
entities.id: 192
entities.type: intervention
entities.text: itraconazole
entities.id: 193
entities.type: intervention
entities.text: fluconazole
entities.id: 194
entities.type: outcome
entities.text: efficacy
entities.id: 195
entities.type: participant
entities.text: patients with AML or MDS who received chemotherapy